Sort
17,288 grants matching “multiple sclerosis”
An Informatics Platform for Objectively Quantifying Electric Power Wheelchair Usage for those with Alzheimer's Disease, Alzheimer's Disease Related Dementias, and Cognitive Impairments
$1,337,053Adam Becker · Innovative Design Labs, Inc. · R44 · FY2021 · AG
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
$1,333,998Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Transcriptional regulation of inflammatory and autoimmune responses
$1,333,998Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Structure-function based development of JC virion specific antagonists for PML
$1,333,900Walter J Atwood · Brown University · P01 · FY2014 · NS
Cellular Mechanisms Of Xenobiotic Transport
$1,332,736Ronald E. Cannon · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging
$1,332,577Julie A Schneider · Rush University Medical Center · R01 · FY2020 · AG
Characterizing TDP-43 related hippocampal degeneration and memory loss in aging
$1,331,164Julie A Schneider · Rush University Medical Center · R01 · FY2021 · AG
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory Disorders
$1,330,618Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Resource for Quantitative Functional MRI
$1,330,370Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2014 · EB
Anti-Viral therapy in Alzheimer's disease
$1,327,757Davangere P Devanand · Columbia University Health Sciences · R01 · FY2017 · AG
Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)
$1,327,494Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2010 · NS
Glycolipid Presentation by CD1d
$1,326,316Albert S. Bendelac · University Of Chicago · P01 · FY2011 · AI
Mechanisms of molecular machines that regulate the neuronal cytoskeleton
$1,325,057Antonina Roll-Mecak · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
From therapeutic mechanisms to unraveling the pathophysiology of MS
$1,324,843Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
CNS Damage from Theiler's Virus Persistence: MS Model
$1,324,554Stephen D Miller · Northwestern University At Chicago · P01 · FY2006 · NS
Glycolipid Presentation by CD1d
$1,324,025Albert S. Bendelac · University Of Chicago · P01 · FY2012 · AI
Sex, Sex Steroids & Neuroprotection
$1,320,895Patricia D. Hurn · Oregon Health & Science University · P01 · FY2009 · NS
Sex, Sex Steroids & Neuroprotection
$1,320,895Patricia D. Hurn · Oregon Health & Science University · P01 · FY2008 · NS
Glycolipid Presentation by CD1d
$1,315,584Albert S. Bendelac · University Of Chicago · P01 · FY2009 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,314,593Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)
$1,314,080Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2011 · NS
Anti-Viral therapy in Alzheimer's disease
$1,312,757Davangere P Devanand · Columbia University Health Sciences · R01 · FY2018 · AG
Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)
$1,310,745Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2009 · NS
Magnetic Resonance Imaging Technology Development
$1,310,082Jozef H Duyn · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)
$1,306,874Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2012 · NS